SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 53.36+3.4%10:31 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (24114)7/19/2007 5:57:57 PM
From: Arthur Radley  Read Replies (1) of 52153
 
Tuck,
Thanks for your previous response on SNUS. Trading activity continues to draw my attention...I'm continuing to nibble at the shares at the $5.00 level.

Do you have any idea as to the market BMY has for Taxol? If the SNUS drug has benefits and less infusion time.....wouldn't BMY want to protect their market share by taking the likes of SNUS out?

Thanks for your input!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News